Pathophysiological Significance of IAPP in NIDDM
Pathophysiological Significance of IAPP in NIDDM
批准号:
03671159
负责人:
MATSUKURA Shigeru
金额:
$1.34万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (C)
财政年份:
1991
资助国家:
日本
项目状态:
已结题
起止时间:
1991 至 1992
中文摘要
胰岛淀粉样多肽(IAPP/Amylin)是一种由37个氨基酸组成的多肽,是非胰岛素依赖型糖尿病(NIDDM)和胰岛素瘤中胰岛淀粉样蛋白的主要成分。为了探讨IAPP在NIDDM中的病理生理意义,我们研究了IAPP在糖尿病患者和糖尿病大鼠模型中的组织含量、血浆水平、基因表达、对生理刺激的反应以及IAPP的免疫组化定位。我们还阐明了形成胰腺淀粉样蛋白的哺乳动物(人和猫)和不形成胰腺淀粉样蛋白的哺乳动物(大鼠和小鼠)的胰腺、胃肠道和血浆中该肽的分子形式。13个胰岛素瘤中有11个对IAPP和胰岛素都有免疫反应,但另外两个只有胰岛素免疫反应。在5例胰岛素瘤中发现淀粉样物沉积,其临床特征将被公布。此外,我们还报道了NIDDM中淀粉样蛋白和胃泌素瘤中淀粉样蛋白的病理特征。胰岛淀粉样蛋白沉积可能是胰岛功能紊乱的继发性表现,但我们不能排除淀粉样蛋白沉积加剧了胰岛功能障碍,并可能参与了NIDDM的进展。
英文摘要
Islet amyloid polypeptide(IAPP/amylin) is a 37 amino acid long peptide, being a major component of islet amyloid in non-insulin-dependent diabetes mellitus(NIDDM) and insulinoma. To delineate the pathophysiological significance of IAPP in NIDDM, we studied tissue content, plasma level, gene expression, response to physiological stimulation and immunohistochemical localization of the peptide in diabetics and rat models of diabetes. We also clarified molecular forms of the peptide in the pancreas, gastrointestinal tract and plasma from mammals that form pancreatic amyloid(human and cat) and mammals that do not form it(rat and mouse). Eleven of thirteen insulinomas had both immunoreactivities for IAPP and insulin, but other two had only insulin-immunoreactivity. Amyloid deposits were noted in 5 insulinomas whose clinical features will be presented. In addition, we report pathological features of amyloid in NIDDM and the amyloid in a gastrinoma. Islet amyloid deposition might be a secondary manifestation of disordered islet function, although we can not exclude that amyloid deposits intensify islet dysfunction and may contribute to the progression of NIDDM.
期刊论文(13)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
中里 雅光,松倉 茂,寒川 賢治,松尾 壽之: "Annual Review内分泌・代謝学" 中外出版社, 8 (1992)
Masamitsu Nakazato、Shigeru Matsukura、Kenji Samukawa、Toshiyuki Matsuo:《内分泌学和代谢年鉴》中外出版社,8(1992)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Miyazato M,Nakazato M,et al Matsukura S: "Identification and characterization of islet amyloid polypeptide(IAPP/amylin)in mammalian gastrointestinal tract." Biochem Biophys Res Commun. 181. 293-300 (1991)
Miyazato M、Nakazato M、et al Matsukura S:“哺乳动物胃肠道中胰岛淀粉样多肽(IAPP/胰淀素)的鉴定和表征。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
M Miyazato,S Matsukura,et al: "Molecular forms of islet amyloid polypeptide(IAPP/amylin)in four mammals." Diabetes Res Clin Pract. 15. 31-36 (1992)
M Miyazato、S Matsukura 等人:“四种哺乳动物中胰岛淀粉样多肽(IAPP/胰淀素)的分子形式。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
T Mitsukawa,S Matsukura,et al: "Effects of aging on plasma islet amyloid polypeptide basal level and response to oral glucose load." Diabetes Res Clin Pract. 15. 131-134 (1992)
T Mitsukawa、S Matsukura 等人:“衰老对血浆胰岛淀粉样多肽基础水平和对口服葡萄糖负荷的反应的影响。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
R Narita,S Matsukura,et al: "Islet amyloid polypeptide(IAPP)and pancreatic islet amyloid deposition in diabetic and non-diabetic patients." Diabetes Res Clin Pract. 15. 3-14 (1992)
R Narita、S Matsukura 等人:“糖尿病和非糖尿病患者中的胰岛淀粉样蛋白多肽 (IAPP) 和胰岛淀粉样蛋白沉积。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 13 条
Uroguanylin in the pathophysiological mechanism in water and electrolyte homeostoses
-
批准号:10670489
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.05万
-
财政年份:1998
-
负责人:MATSUKURA Shigeru
-
依托单位:
Cellular Physiology and molecular biology of amylin in NIDDM
-
批准号:07457226
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$4.22万
-
财政年份:1995
-
负责人:MATSUKURA Shigeru
-
依托单位:
国内基金
海外基金
中枢神经系统MC4R神经元介导Amylin促进背肩胛棕色脂肪产热的研究
-
批准号:32060204
-
项目类别:地区科学基金项目
-
资助金额:37.0万元
-
批准年份:2020
-
负责人:杜晨光
-
依托单位:
Amylin在糖尿病血管内皮屏障功能损伤中的作用和机制研究
-
批准号:30871202
-
项目类别:面上项目
-
资助金额:34.0万元
-
批准年份:2008
-
负责人:彭艾
-
依托单位: